Found 8 matching trials
Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy
N/AProlonged anti CD20 therapy for the treatment of active multiple sclerosis ...
Location
Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano
Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations
PHASE2To learn about the safety and tolerability of study drug combinations in pa...
Location
MD Anderson Cancer Center
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NAAcute myeloid leukemia (AML) is one of the most common hematologic malignan...
Location
The First Affiliated Hospital of Soochow University
Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma
PHASE2This study is to explore the efficacy and safety of ChiCGB conditioning the...
Location
Multiple Locations
Cladribine Venetoclax in Monocytic AML
PHASE2Investigation of Relapsed or refractory AML with a monocytic phenotype afte...
Status
Active Not Recruiting
Location
Universtiy of Colorado Hospital
Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
PHASE1To determine the efficacy of the combination of tagraxofusp, cladribine, an...
Location
Stanford University
Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma
PHASE2The goal of this clinical research study is to evaluate effectiveness and s...
Location
Beijing cancer hospital
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
N/AThe main aim was to study in the real world setting the effectiveness of Cl...
Location
KH der Barmherzige Brüder Eisenstadt - Neurology